Shri Ahimsa Naturals Q4 FY26 Share Price & Earnings Call Analysis
- Market cap
- ₹949 Cr
- P/E
- 31.65
- ROE
- 17.18%
- PEG
- -5.59
- Price to sales
- 7.69
- Debt to equity
- 0.05
- 52W high / low
- ₹494 / ₹222
- Sales growth (5Y)
- 34.57%
- EBITDA margin
- 29.06%
- Net profit margin
- 24.31%
- Promoter holding
- 67.83%
- Sales (last year)
- ₹123 Cr
Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts.[1]
Potential multibaggers · Q2 FY27
Potential multibaggers in Food Products
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Peers
Food Products companies ranked on guidance
| # | Company | Revenue guided | Margin guided | Market cap | P/E |
|---|---|---|---|---|---|
| 1 | 40%+ | Up 2%+ | ₹23,562 Cr | 134.3 | |
| 2 | 40%+ | Up 2%+ | ₹435 Cr | 7.5 | |
| 3 | 40%+ | Up 2%+ | ₹413 Cr | 72.6 | |
| 4 | 40%+ | Flat | ₹1,012 Cr | 46.0 | |
| 5 | 40%+ | Flat | ₹148 Cr | 9.8 | |
| 6 | 20–40% | Up 2%+ | ₹670 Cr | 48.3 |
Sign up free to see every company in the sector ranking and track Shri Ahimsa.
Pro shows every company guiding 40%+ revenue growth →Full Food Products rankingFinancials of Shri Ahimsa
Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.
Financials of Shri Ahimsa
Quarterly Results
Quarter-by-quarter operating performance
Financials of Shri Ahimsa
Profit & Loss
Annual income statement trend
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales + | 22 | 28 | 58 | 104 | 78 | 96 | 123 |
| Expenses + | 18 | 24 | 41 | 54 | 51 | 65 | 87 |
| Operating Profit | 4 | 4 | 17 | 50 | 27 | 31 | 36 |
| OPM % | 17% | 15% | 30% | 48% | 34% | 32% | 29% |
| Other Income + | 1 | 0 | 1 | 2 | 1 | 2 | 7 |
| Interest | 2 | 1 | 2 | 1 | 1 | 1 | 1 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Profit before tax | 2 | 2 | 16 | 51 | 25 | 30 | 40 |
| Tax % | 27% | 32% | 30% | 29% | 26% | 26% | 26% |
| Net Profit + | 1 | 2 | 11 | 36 | 19 | 22 | 30 |
| EPS in Rs | 3.44 | 3.37 | 21.53 | 68.21 | 10.21 | 9.42 | 12.84 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Financials of Shri Ahimsa
Balance Sheet
Capital structure and asset base
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Equity Capital | 3 | 5 | 5 | 5 | 18 | 23 | 23 |
| Reserves | 6 | 9 | 22 | 58 | 66 | 131 | 171 |
| Borrowings + | 14 | 13 | 6 | 3 | 14 | 0 | 9 |
| Other Liabilities + | 4 | 4 | 7 | 8 | 5 | 38 | 5 |
| Total Liabilities | 27 | 31 | 41 | 74 | 103 | 193 | 208 |
| Fixed Assets + | 15 | 17 | 21 | 28 | 32 | 39 | 38 |
| CWIP | 0 | 1 | 3 | 3 | 6 | 2 | 0 |
| Investments | 0 | 0 | 0 | 1 | 10 | 10 | 35 |
| Other Assets + | 12 | 12 | 17 | 42 | 55 | 143 | 135 |
| Total Assets | 27 | 31 | 41 | 74 | 103 | 193 | 208 |
Financials of Shri Ahimsa
Cash Flows
Operating, investing and financing cash movement
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from Operating Activity + | 6 | 3 | 14 | 20 | 6 | 43 | |
| Cash from Investing Activity + | -1 | -4 | -6 | -10 | -19 | -3 | |
| Cash from Financing Activity + | -5 | 1 | -6 | -4 | 10 | 34 | |
| Net Cash Flow | 0 | -0 | 3 | 7 | -4 | 74 | |
| Free Cash Flow | 5 | -1 | 9 | 10 | -2 | 39 | |
| CFO/OP | 162% | 84% | 91% | 68% | 46% | 161% |
Financials of Shri Ahimsa
Ratios
Working capital efficiency and return ratios
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Debtor Days | 53 | 62 | 25 | 39 | 53 | 96 | 86 |
| Inventory Days | 201 | 61 | 77 | 122 | 340 | 214 | 181 |
| Days Payable | 45 | 33 | 15 | 8 | 18 | 3 | 2 |
| Cash Conversion Cycle | 209 | 90 | 87 | 154 | 375 | 307 | 265 |
| Working Capital Days | -30 | -3 | 26 | 74 | 133 | 92 | 186 |
| ROCE % | 14% | 58% | 102% | 32% | 24% | 23% |
Momentum score · price trend
87 out of 100 — Strengthening
Over the past year its share price has done better than most of the stocks we track.
| Period | Share price change | Better than … of 1,910 stocks |
|---|---|---|
| Last 12 months | +64.6% | 89% |
| Last 6 months | +50.4% | 90% |
| Last 3 months | +4.4% | 75% |
How we calculate it
“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).
The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Shri Ahimsa: 0.4 × 89 + 0.4 × 90 + 0.2 × 75 = 87.
Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.
Full methodology →This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.
Continue your research
What Shri Ahimsa's management said in earlier quarters
Others in Food Products this season
- Zydus Wellness (Q2 FY27)
Net Sales for Q2 FY27: INR 11,227 million, up 74.6% YoY from INR 6,429 million in Q2 FY26. Key investor presentation takeaways from Zydus Wellness Ltd's Q2 FY27
- Hoac Foods (Q2 FY27)
Revenue from operations (gross) for the quarter ended September 30, 2026, is ₹2,326.15 lakh (Standalone) and ₹2,314.04 lakh (Consolidated). Key results statemen
- Narmada Agrobase (Q2 FY27)
EBITDA for the quarter ended September 30, 2026: ₹2303.54 lakhs, up from ₹2153.41 lakhs in the same quarter last year (YoY increase). Key results statement take
- Dangee Dums (Q2 FY27)
700.42 lakhs for the quarter ended September 30, 2025, reflecting a year-on-year increase of approximately 13.37%. Key results statement takeaways from Dangee D
